144 related articles for article (PubMed ID: 37437754)
1. Phospholipid binding of the dengue virus envelope E protein segment containing the conserved His residue.
Villalaín J
Biochim Biophys Acta Biomembr; 2023 Oct; 1865(7):184198. PubMed ID: 37437754
[TBL] [Abstract][Full Text] [Related]
2. Envelope E protein of dengue virus and phospholipid binding to the late endosomal membrane.
Villalaín J
Biochim Biophys Acta Biomembr; 2022 May; 1864(5):183889. PubMed ID: 35167815
[TBL] [Abstract][Full Text] [Related]
3. Identification of the phospholipid binding regions of the envelope E protein of flaviviruses by molecular dynamics.
Carpio LE; Villalaín J
J Biomol Struct Dyn; 2020 Oct; 38(17):5136-5147. PubMed ID: 31779533
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of flavivirus membrane fusion.
Stiasny K; Fritz R; Pangerl K; Heinz FX
Amino Acids; 2011 Nov; 41(5):1159-63. PubMed ID: 19882217
[TBL] [Abstract][Full Text] [Related]
5. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
[TBL] [Abstract][Full Text] [Related]
6. Constancy and diversity in the flavivirus fusion peptide.
Seligman SJ
Virol J; 2008 Feb; 5():27. PubMed ID: 18275613
[TBL] [Abstract][Full Text] [Related]
7. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
8. Human Claudin-Derived Peptides Block the Membrane Fusion Process of Zika Virus and Are Broad Flavivirus Inhibitors.
Zoladek J; Burlaud-Gaillard J; Chazal M; Desgraupes S; Jeannin P; Gessain A; Pardigon N; Hubert M; Roingeard P; Jouvenet N; Afonso PV
Microbiol Spectr; 2022 Oct; 10(5):e0298922. PubMed ID: 36040168
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
[TBL] [Abstract][Full Text] [Related]
10. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
[TBL] [Abstract][Full Text] [Related]
11. Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses.
Martín-Acebes MA; Vázquez-Calvo Á; Saiz JC
Prog Lipid Res; 2016 Oct; 64():123-137. PubMed ID: 27702593
[TBL] [Abstract][Full Text] [Related]
12. Flavivirus Entry Inhibitors.
Yu Y; Si L; Meng Y
Adv Exp Med Biol; 2022; 1366():171-197. PubMed ID: 35412141
[TBL] [Abstract][Full Text] [Related]
13. Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy
Celegato M; Sturlese M; Vasconcelos Costa V; Trevisan M; Lallo Dias AS; Souza Passos IB; Queiroz-Junior CM; Messa L; Favaro A; Moro S; Teixeira MM; Loregian A; Mercorelli B
mBio; 2023 Feb; 14(1):e0309722. PubMed ID: 36622141
[TBL] [Abstract][Full Text] [Related]
14. Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membrane.
Oeyen M; Meyen E; Noppen S; Claes S; Doijen J; Vermeire K; Süssmuth RD; Schols D
Virology; 2021 Oct; 562():74-86. PubMed ID: 34274562
[TBL] [Abstract][Full Text] [Related]
15. The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion.
Yamamoto M; Ichinohe T; Watanabe A; Kobayashi A; Zhang R; Song J; Kawaguchi Y; Matsuda Z; Inoue JI
Viruses; 2020 Dec; 12(12):. PubMed ID: 33371476
[TBL] [Abstract][Full Text] [Related]
16. Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus.
Yang X; Qi J; Peng R; Dai L; Gould EA; Gao GF; Tien P
J Virol; 2019 Apr; 93(8):. PubMed ID: 30760569
[TBL] [Abstract][Full Text] [Related]
17. Peptide inhibitors of dengue virus and West Nile virus infectivity.
Hrobowski YM; Garry RF; Michael SF
Virol J; 2005 Jun; 2():49. PubMed ID: 15927084
[TBL] [Abstract][Full Text] [Related]
18. New insights into flavivirus biology: the influence of pH over interactions between prM and E proteins.
Oliveira ERA; de Alencastro RB; Horta BAC
J Comput Aided Mol Des; 2017 Nov; 31(11):1009-1019. PubMed ID: 29064083
[TBL] [Abstract][Full Text] [Related]
19. Direct Activation of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by PF-06409577 Inhibits Flavivirus Infection through Modification of Host Cell Lipid Metabolism.
Jiménez de Oya N; Blázquez AB; Casas J; Saiz JC; Martín-Acebes MA
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712653
[TBL] [Abstract][Full Text] [Related]
20. Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation.
Panayiotou C; Lindqvist R; Kurhade C; Vonderstein K; Pasto J; Edlund K; Upadhyay AS; Överby AK
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
